Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Olig2 Antibody, Novus Biologicals™

Sheep Polyclonal Antibody
Supplier: Novus Biologicals NBP130650
Description
Olig2 Polyclonal specifically detects Olig2 in Human, Mouse, Rat samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry-Frozen.Specifications
| Olig2 | |
| Polyclonal | |
| Unconjugated | |
| Lyophilized from whole antisera with No Preservative | |
| OLIG2 | |
| A synthetic peptide from the n-terminal region of human Olig2 conjugated to blue carrier protein was used as the antigen. The peptide is homologous in rat and mouse. | |
| 0.1 mL | |
| Cellular Markers | |
| 10215 | |
| Reconstitute in 0.1 ml of sterile water. Centrifuge to remove any insoluble material. Glycerol may be added (1:1) for additional stability. Please note the sample size is provided in reconstituted format. | |
| Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
| IgG |
| Western Blot, Immunohistochemistry, Immunohistochemistry (Frozen) | |
| LYOPH | |
| Western Blot 1:300-1:2000, Immunohistochemistry 1:300-1:2000, Immunohistochemistry-Frozen 1:300-1:2000 | |
| BHLHB1, BHLHE19, Class B basic helix-loop-helix protein 1, Class E basic helix-loop-helix protein 19, human protein kinase C-binding protein RACK17, OLIGO2, oligodendrocyte lineage transcription factor 2, oligodendrocyte transcription factor 2, oligodendrocyte-specific bHLH transcription factor 2, protein kinase C binding protein 2, Protein kinase C-binding protein 2, Protein kinase C-binding protein RACK17, RACK17helix-loop-helix protein, class B, 1 | |
| Sheep | |
| Unpurified | |
| RUO | |
| Primary | |
| Appears to be specific for OLIG2. | |
| Human, Mouse, Rat | |
| Antisera |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction